Skip to main content

Table 3 Locoregional recurrence, distant metastasis, and survival outcomes for patients with limited stage small cell lung cancer (LS-SCLC) treated with chemoradiation, (n = 105)

From: The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer

OutcomesRate
Two-year LRRa38%
Two-year in-field LRR rate31%
Median time to LRR (months, range)8.6 (2.5–47.3)
Median time to in-field LRR (months, range)8.5 (2.5–47.3)
Two-year DMb rate52%
Median time to DM (months)8.8 (1.6–74.5)
Two-year any progression rate62%
Median time to any progression (months, range)8.4 (1.6–26.2)
Two-year OSc rate47%
Median survival (months, range)16.5 (0.6–98.6)
  1. aLRR loco-regional recurrence, bDM distant metastasis, cOS overall survival